3320 — China Resources Pharmaceutical Cashflow Statement
0.000.00%
Last trade - 00:00- HK$34.05bn
- HK$90.96bn
- CNY244.70bn
- 82
- 95
- 76
- 98
Annual cashflow statement for China Resources Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | Final | Final |
| Net Income/Starting Line | 5,854 | 6,294 | 6,978 | 8,361 | 9,880 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2,657 | 3,510 | 2,760 | 2,726 | 3,211 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3,418 | -4,678 | -1,422 | -2,824 | -705 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 7,178 | 7,300 | 10,658 | 10,821 | 15,550 |
| Capital Expenditures | -1,784 | -1,974 | -2,524 | -2,740 | -3,133 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 2,673 | -32.1 | -5,104 | 1,921 | 1,065 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 889 | -2,006 | -7,628 | -819 | -2,067 |
| Financing Cash Flow Items | 5,133 | -5,196 | -1,571 | -7,491 | -213 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -11,470 | -5,706 | 2,494 | -9,126 | -4,065 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3,604 | -1,171 | 5,224 | 908 | 9,427 |